Dr. Min-young Lee and Dr. Sung-gyu Park of the Advanced Bio and Healthcare Materials Research Division at KIMS have developed ...

NanoVation Therapeutics partners with Novo Nordisk to develop genetic medicines for cardiometabolic and rare diseases, utilizing NanoVation's lipid nanoparticle technology. The deal includes research ...

Genetic modification in horticultural crops, particularly within the Cucurbitaceae family, is often hindered by complex ...

The Senate Judiciary Committee is scheduled to consider two bills Thursday that would effectively nullify the Supreme Court's ...

All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the ...

Novo Nordisk is continuing its push into genetic medicines, agreeing to pay NanoVation Therapeutics up to $600 million to ...

MELBOURNE, Australia, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and ...

CREME, an AI-powered virtual lab, developed at Cold Spring Harbor Laboratory, offers a revolutionary approach to genetic ...

Scientists searching for the origins of COVID-19 have zeroed in on a short list of animals that possibly helped spread it to ...

The introduction of genetic and brain markers provides guidance for future precision care in autism spectrum disorders.